Cite
HARVARD Citation
Tobe, K. et al. (2019). Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study. Journal of diabetes investigation. 10 (5), pp. 1262-1271. [Online].